ZWILCH
Basic information
Region (hg38): 15:66504959-66550130
Links
Phenotypes
GenCC
Source:
- autism spectrum disorder (Limited), mode of inheritance: AD
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the ZWILCH gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 1 | |||||
missense | 26 | 30 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 1 | 1 | ||||
non coding | 4 | |||||
Total | 0 | 0 | 29 | 4 | 2 |
Variants in ZWILCH
This is a list of pathogenic ClinVar variants found in the ZWILCH region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
15-66505372-T-A | not specified | Uncertain significance (May 05, 2023) | ||
15-66505387-C-T | Benign (Mar 30, 2018) | |||
15-66513989-C-G | not specified | Uncertain significance (May 07, 2024) | ||
15-66514024-C-A | not specified | Uncertain significance (Jul 13, 2021) | ||
15-66515599-C-T | not specified | Uncertain significance (Apr 04, 2024) | ||
15-66515640-G-T | not specified | Uncertain significance (Jan 02, 2024) | ||
15-66518964-C-T | not specified | Uncertain significance (Feb 23, 2023) | ||
15-66519031-C-G | Likely benign (Nov 01, 2022) | |||
15-66519061-A-G | not specified | Uncertain significance (Oct 04, 2022) | ||
15-66520624-A-G | Likely benign (Nov 01, 2022) | |||
15-66520649-C-T | not specified | Uncertain significance (Feb 22, 2024) | ||
15-66521041-T-G | Benign (May 21, 2018) | |||
15-66521147-C-A | not specified | Uncertain significance (Dec 12, 2023) | ||
15-66523689-G-A | not specified | Uncertain significance (May 15, 2024) | ||
15-66523695-G-C | not specified | Uncertain significance (Mar 15, 2024) | ||
15-66527308-A-G | not specified | Uncertain significance (Nov 22, 2021) | ||
15-66527329-C-T | not specified | Uncertain significance (Mar 19, 2024) | ||
15-66527899-A-G | not specified | Uncertain significance (Jan 10, 2022) | ||
15-66528879-G-T | not specified | Uncertain significance (Jan 06, 2023) | ||
15-66528883-G-A | not specified | Uncertain significance (Jan 10, 2023) | ||
15-66528886-C-A | not specified | Uncertain significance (Mar 13, 2023) | ||
15-66528886-C-T | not specified | Uncertain significance (Mar 24, 2023) | ||
15-66528894-C-T | not specified | Likely benign (May 05, 2023) | ||
15-66528910-G-T | not specified | Uncertain significance (Jan 19, 2022) | ||
15-66529530-C-T | not specified | Uncertain significance (Dec 18, 2023) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
ZWILCH | protein_coding | protein_coding | ENST00000307897 | 18 | 44819 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
1.20e-13 | 0.482 | 125688 | 0 | 60 | 125748 | 0.000239 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | -0.387 | 317 | 298 | 1.06 | 0.0000142 | 3911 |
Missense in Polyphen | 107 | 95.743 | 1.1176 | 1348 | ||
Synonymous | -0.626 | 110 | 102 | 1.08 | 0.00000501 | 1055 |
Loss of Function | 1.46 | 25 | 34.2 | 0.731 | 0.00000145 | 449 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000318 | 0.000311 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.000220 | 0.000217 |
Finnish | 0.0000930 | 0.0000924 |
European (Non-Finnish) | 0.000259 | 0.000255 |
Middle Eastern | 0.000220 | 0.000217 |
South Asian | 0.000474 | 0.000457 |
Other | 0.000522 | 0.000489 |
dbNSFP
Source:
- Function
- FUNCTION: Essential component of the mitotic checkpoint, which prevents cells from prematurely exiting mitosis. Required for the assembly of the dynein-dynactin and MAD1-MAD2 complexes onto kinetochores. Its function related to the spindle assembly machinery is proposed to depend on its association in the mitotic RZZ complex (PubMed:15824131). {ECO:0000269|PubMed:15824131}.;
- Pathway
- Signal Transduction;Amplification of signal from unattached kinetochores via a MAD2 inhibitory signal;Amplification of signal from the kinetochores;Mitotic Spindle Checkpoint;Cell Cycle Checkpoints;RHO GTPases Activate Formins;RHO GTPase Effectors;Signaling by Rho GTPases;Mitotic Prometaphase;Separation of Sister Chromatids;Mitotic Anaphase;Mitotic Metaphase and Anaphase;M Phase;Cell Cycle;Resolution of Sister Chromatid Cohesion;Cell Cycle, Mitotic
(Consensus)
Recessive Scores
- pRec
- 0.0773
Intolerance Scores
- loftool
- 0.914
- rvis_EVS
- 0.04
- rvis_percentile_EVS
- 57.41
Haploinsufficiency Scores
- pHI
- 0.363
- hipred
- N
- hipred_score
- 0.321
- ghis
- 0.643
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- E
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.434
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Zwilch
- Phenotype
- growth/size/body region phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); embryo phenotype;
Gene ontology
- Biological process
- mitotic cell cycle checkpoint;cell division
- Cellular component
- kinetochore;condensed chromosome kinetochore;cytosol;RZZ complex
- Molecular function
- protein binding